- Filed
- May 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 5, 2025 | 220.6M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $683.69K |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $1.74M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $1.62M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $2.73M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $2.55M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.96M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $374.16K |
| Total Assets | Q1 2025 · Dec 31, 2024 | $2.92M |
| Total Assets restated | Q1 2025 · Mar 31, 2024 | $2.92M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 199.03M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $8.82K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$280.93K |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $1.26M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $1.16M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.00 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.00 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $505.89K |
| Net Income | Q1 2025 · Mar 31, 2024 | −$302.39K |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$305.15K |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $294.82K |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $389.84K |
| Revenue | Q1 2025 · Mar 31, 2024 | $684.66K |